Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Characterisation of uveitis in association with multiple sclerosis.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Minocycline Hydrochloride (1818)
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.
Primary varicella zoster infection associated with fingolimod treatment.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
[Biomarkers in multiple sclerosis].
Design and analysis of three-arm trials with negative binomially distributed endpoints.
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Oral laquinimod for multiple sclerosis.
The New Era of Multiple Sclerosis Therapeutics.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls.
[New treatment options in multiple sclerosis and their complications].
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
Reducing falls and improving mobility in multiple sclerosis.
Natalizumab-induced hepatic injury: A case report and review of literature.
Viruses and Multiple Sclerosis.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »